Literature DB >> 24753546

Prospective examination of objectively assessed physical activity and sedentary time after breast cancer treatment: sitting on the crest of the teachable moment.

Catherine M Sabiston1, Jennifer Brunet2, Jeff K Vallance3, Sarkis Meterissian4.   

Abstract

BACKGROUND: This study prospectively examined patterns of objectively assessed sedentary time and moderate-to-vigorous physical activity (MVPA) during a 1-year period following completion of primary treatment among breast cancer survivors. The potential moderating effect of weight status on sedentary and MVPA time was also examined.
METHODS: Breast cancer survivors [n = 177; M(SD)age = 54.9 (11.1) years, 85% White/Caucasian; 82% stage I or II cancer; M(SD)time since treatment = 3.5 (2.4) months] who were recruited into a convenience sample had weight, height, and waist circumference measured and wore Actigraph GT3X accelerometers for 1 week every 3 months for 1 year. Data were analyzed using repeated measures ANOVA.
RESULTS: Survivors spent nearly 78% of their day sedentary across all time points compared with less than 2% of their day engaged in MVPA. Sedentary time remained fairly stable over 12 months, whereas MVPA levels significantly decreased. Survivors with an overweight body mass index and unhealthy waist-to-height ratio engaged in significantly less MVPA than healthy weight survivors, with significant waist-to-height ratio moderator effects for both sedentary and MVPA.
CONCLUSIONS: Sedentary time remains high in the first year following treatment for breast cancer, and MVPA decreases. These trends are more pronounced for survivors who are overweight, with stronger effects noted when waist-to-height ratio was examined compared with body mass index. IMPACT: These findings suggest that breast cancer survivors may be doing very little to improve their lifestyle behaviors following a cancer diagnosis and treatments. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 24753546     DOI: 10.1158/1055-9965.EPI-13-1179

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  40 in total

1.  Aromatase inhibitor associated arthralgia: the importance of oncology provider-patient communication about side effects and potential management through physical activity.

Authors:  Kirsten A Nyrop; Leigh F Callahan; Christine Rini; Mary Altpeter; Betsy Hackney; Amy DePue; Anne Wilson; Arielle Schechter; Hyman B Muss
Journal:  Support Care Cancer       Date:  2016-01-12       Impact factor: 3.603

2.  Preferences for mHealth physical activity interventions during chemotherapy for breast cancer: a qualitative evaluation.

Authors:  Anne M Nielsen; Whitney A Welch; Kara L Gavin; Alison M Cottrell; Payton Solk; Emily A Torre; Danielle Blanch-Hartigan; Siobhan M Phillips
Journal:  Support Care Cancer       Date:  2019-07-31       Impact factor: 3.603

3.  Accelerometer determined lifestyle behaviors over time-letter.

Authors:  Bernardine M Pinto; Wendy Demark-Wahnefried; Julia H Rowland; Noreen M Aziz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11       Impact factor: 4.254

4.  Exploring cancer centres for physical activity and sedentary behaviour support for breast cancer survivors.

Authors:  A J Fong; J M Jones; G Faulkner; C M Sabiston
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

5.  Patient's lung cancer diagnosis as a cue for relatives' smoking cessation: evaluating the constructs of the teachable moment.

Authors:  Colleen M McBride; Michelle Blocklin; Isaac M Lipkus; William M P Klein; Thomas H Brandon
Journal:  Psychooncology       Date:  2015-10-30       Impact factor: 3.894

6.  A qualitative analysis of oncology clinicians' perceptions and barriers for physical activity counseling in breast cancer survivors.

Authors:  Angela J Fong; Guy Faulkner; Jennifer M Jones; Catherine M Sabiston
Journal:  Support Care Cancer       Date:  2018-03-24       Impact factor: 3.603

7.  Breast cancer survivors reduce accelerometer-measured sedentary time in an exercise intervention.

Authors:  Lauren S Weiner; Michelle Takemoto; Suneeta Godbole; Sandahl H Nelson; Loki Natarajan; Dorothy D Sears; Sheri J Hartman
Journal:  J Cancer Surviv       Date:  2019-05-29       Impact factor: 4.442

8.  Continuous, objective measurement of physical activity during chemotherapy for breast cancer: the Activity in Treatment pilot study.

Authors:  Sandahl H Nelson; Lauren S Weiner; Loki Natarajan; Barbara A Parker; Ruth E Patterson; Sheri J Hartman
Journal:  Transl Behav Med       Date:  2020-10-08       Impact factor: 3.046

9.  A comparison of total and domain-specific sedentary time in breast cancer survivors and age-matched healthy controls.

Authors:  Allyson Tabaczynski; Alexis Whitehorn; Edward McAuley; Linda Trinh
Journal:  J Behav Med       Date:  2020-11-13

10.  Changes in light-, moderate-, and vigorous-intensity physical activity and changes in depressive symptoms in breast cancer survivors: a prospective observational study.

Authors:  Benjamin D Sylvester; Rashid Ahmed; Steve Amireault; Catherine M Sabiston
Journal:  Support Care Cancer       Date:  2017-05-11       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.